Class IITerminatedVoluntary: Firm initiated
Yerba Prima Inc: food recall H-0050-2025
Yerba Prima Inc of Ashland, OR recalled Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and… Reason: Potential contamination with Pseudomonas aeruginosa. The FDA listed it as Class II in its Enforcement Report dated Jun 25, 2025; distribution: Arizona, California, Colorado, Connecticut, Florida, Georgia, Iowa, Illinois, Indiana, Kentucky, Maryland, Missouri, North Carolina, New Hampshire, Nevada, New York, Ohio, Pennsylvania, Texas, Virginia, Washington.
Record status as published: Terminated (terminated Sep 5, 2025). openFDA data last updated Oct 21, 2026.
Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.
Recall details
- Product
- Great Plains Bentonite + Herbal Detox Capsules 60 capsules, packaged in PETE amber bottle, white plastic cap and tamper proof seal. Case GTIN code:100 46352 00518 5. Retail package UPC code: 0 46352 00518 8. Yerba Prima, Inc. 740 Jefferson Ave Ashland, Oregon 97520 USA
- Product quantity
- 4985 bottles
- Reason for recall
- Potential contamination with Pseudomonas aeruginosa.
- Codes, lots and dates on the package
- Lot # 05051, Expiration Date 02/2028. Lot code breaks down as follows: 050 = 3 digits pertaining to the day of the year 5 = last number of the year 2025 1 = number of batch records issued of the day
- Distribution pattern
- Distributed in AZ, CA, CO, CT, FL, GA, IA, IL, IN, KY, MD, MO, NC, NH, NV, NY, OH, PA, TX, VA, and WA.
- Recalling firm
- Yerba Prima Inc, Ashland, OR
- Classification
- Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
- Voluntary or mandated
- Voluntary: Firm initiated
- How the firm first notified customers
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Advertisement
Dates
| Event | Date |
|---|---|
| Recall initiated by the firm | Jun 10, 2025 |
| Classified by the FDA | Jun 17, 2025 |
| Published in the Enforcement Report | Jun 25, 2025 |
| Terminated | Sep 5, 2025 |
Advertisement
OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.
Sources
- U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-0050-2025 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
- Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.